Menu

• Ask a Health Expert about METASTASES TO MENINGES
• Post Your Side Effect related to METASTASES TO MENINGES
• METASTASES TO MENINGES and FDA Warnings
• METASTASES TO MENINGES in Patients Wiki
• Report METASTASES TO MENINGES in Drug Side Effect Survey

METASTASES TO MENINGES side effect

What is METASTASES TO MENINGES ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Clamoxyl Side Effects Report #5726459-5
Consumer or non-health professional from FRANCE reported CLAMOXYL problem on Apr 29, 2008. Male patient, 20 years of age, was diagnosed with dental disorder prophylaxis and was treated with CLAMOXYL. After drug was administered, patient experienced the following problems/side effects: metastases to meninges, pyrexia, vomiting, . CLAMOXYL dosage: unknown. During the same period patient was treated with EFFERALGAN CODEINE. Patient was hospitalized. Patient recovered.

Relpax Side Effects Report #5649621-9
RELPAX problem was reported by a Consumer or non-health professional from JAPAN on Feb 21, 2008. Female patient, 52 years of age, was diagnosed with headache and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: csf test abnormal, metastases to meninges, . RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.

Sorafenib Side Effects Report #5535678-2
Physician from HONG KONG reported SORAFENIB problem on Dec 03, 2007. Female patient, 63 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: confusional state, metastases to meninges, muscle spasms, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient died on 11/27/2007.

Sorafenib Side Effects Report #5568374-6
SORAFENIB problem was reported by a Physician from HONG KONG on Dec 12, 2007. Female patient, 63 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: confusional state, metastases to meninges, muscle spasms, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized. Patient died on 11/27/2007.


Relpax Side Effects Report #5524284-1
Consumer or non-health professional from JAPAN reported RELPAX problem on Nov 11, 2007. Female patient, 52 years of age, was diagnosed with headache and was treated with RELPAX. After drug was administered, patient experienced the following problems/side effects: csf test abnormal, metastases to meninges, . RELPAX dosage: unknown. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5498418-1
ABRAXANE problem was reported by a Physician from UNITED STATES on Oct 09, 2007. Female patient, 78 years of age, weighting 112.4 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion, metastases to meninges, . ABRAXANE dosage: 150 MG, INTRAVENOUS. During the same period patient was treated with VITAMIN, OSCAL, ASPIRIN, LISINOPRIL, COREG, MIRALAX. Patient was hospitalized and became disabled. Patient recovered.

Sorafenib Side Effects Report #5391238-8
Consumer or non-health professional from FRANCE reported SORAFENIB problem on July 12, 2007. Male patient, 68 years of age, weighting 154.3 lb, was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, metastases to meninges, myocardial ischaemia, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized and became disabled. Patient died on 05/08/2007.

Sorafenib Side Effects Report #5392227-X
SORAFENIB problem was reported by a Consumer or non-health professional from FRANCE on July 12, 2007. Male patient, 68 years of age, weighting 154.3 lb, was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, metastases to meninges, myocardial ischaemia, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized and became disabled. Patient died on 05/08/2007.

Sorafenib Side Effects Report #5391238-8
Consumer or non-health professional from FRANCE reported SORAFENIB problem on July 12, 2007. Male patient, 68 years of age, weighting 154.3 lb, was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, metastases to meninges, myocardial ischaemia, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized and became disabled. Patient died on 05/08/2007.


Sorafenib Side Effects Report #5392227-X
SORAFENIB problem was reported by a Consumer or non-health professional from FRANCE on July 12, 2007. Male patient, 68 years of age, weighting 154.3 lb, was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, metastases to meninges, myocardial ischaemia, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized and became disabled. Patient died on 05/08/2007.

Sorafenib Side Effects Report #5336838-6
Consumer or non-health professional from FRANCE reported SORAFENIB problem on May 14, 2007. Male patient, 68 years of age, weighting 154.3 lb, was treated with SORAFENIB. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, metastases to meninges, myocardial ischaemia, . SORAFENIB dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient was hospitalized and became disabled. Patient died on 05/08/2007.

Vincristine Side Effects Report #5622168-1
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 29, 2008. Female patient, 15 years of age, was diagnosed with astrocytoma, low grade and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: astrocytoma, low grade, gene mutation identification test positive, metastases to meninges, neoplasm progression, primitive neuroectodermal tumour, . VINCRISTINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, IFOSFAMIDE, VALPROIC ACID, RADIATION. Patient died.

Arixtra Side Effects Report #5492041-0
Physician from UNITED STATES reported ARIXTRA problem on Oct 18, 2007. Male patient, 66 years of age, weighting 231.5 lb, was treated with ARIXTRA. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen abnormal, cerebral haemorrhage, metastases to meninges, platelet count abnormal, . ARIXTRA dosage: 5MG DAILY SQ. Patient recovered.

Exjade Side Effects Report #5466585-1
EXJADE problem was reported by a Physician from FRANCE on Sept 17, 2007. Female patient, 58 years of age, weighting 134.5 lb, was diagnosed with myeloid leukaemia and was treated with EXJADE. After drug was administered, patient experienced the following problems/side effects: blast crisis in myelogenous leukaemia, lumbar puncture, metastases to meninges, numb chin syndrome, papilloedema, vision blurred, visual acuity reduced, visual field defect, . EXJADE dosage: 1250 MG, QD. Patient was hospitalized. Patient recovered.


Tarceva Side Effects Report #5712027-8
Health Professional from ITALY reported TARCEVA problem on Apr 03, 2008. Female patient, 50 years of age, was diagnosed with lung adenocarcinoma metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: axonal neuropathy, diplegia, metastases to meninges, paraesthesia, paraneoplastic syndrome, . TARCEVA dosage: (150 MG,QD),ORAL. During the same period patient was treated with DELTA. Patient recovered.